References
- Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., …
& Chen, H. D. (2020). A pneumonia outbreak associated with a new
coronavirus of probable bat origin. Nature , 579 (7798),
270-273.
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., … & Niu,
P. (2020). A novel coronavirus from patients with pneumonia in China,
2019. New England Journal of Medicine .
- ”WHO Director-General’s opening remarks at the media briefing on
COVID-19”
(https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020).
World Health Organization (WHO) (Press release). 11 March 2020.
Archived
(https://web.archive.org/web/20200311212521/https://www.who.int/dg/speeches/detail/who-director-general-sopening-remarks-at-the-media-briefing-on-covid-19—11-march-2020)
from the original on 11 March 2020. Retrieved 10 May 2020.
- ”https://www.worldometers.info/coronavirus/”, Author:
Worldometers.info, Publishing Date: 10 May, 2020, Place of
publication: Dover, Delaware, U.S.A.
- World Health Organization. (2020). Infection prevention and control
during health care when COVID-19 is suspected: interim guidance, 19
March 2020 (No. WHO/2019-nCoV/IPC/2020.3). World Health Organization.
- World Health Organization. (2020). Rational use of personal protective
equipment for coronavirus disease ( COVID-19) and considerations
during severe shortages: interim guidance, 6 April 2020 (No.
WHO/2019-nCov/IPC_PPE_use/2020.3). World Health Organization.
- Pui, C. H., Relling, M. V., Sandlund, J. T., Downing, J. R., Campana,
D., & Evans, W. E. (2004). Rationale and design of Total Therapy
Study XV for newly diagnosed childhood acute lymphoblastic
leukemia. Annals of hematology , 83 , S124-6.
- Felice MS, Rossi JG, Gallego MS, et al.: No advantage of a rotational
continuation phase in acute lymphoblastic leukemia in childhood
treated with a BFM back-bone therapy. Pediatr Blood Cancer 57
(1):47-55, 2011
- Rubnitz, J. E., Inaba, H., Dahl, G., Ribeiro, R. C., Bowman, W. P.,
Taub, J., … & Meshinchi, S. (2010). Minimal residual
disease-directed therapy for childhood acute myeloid leukaemia:
results of the AML02 multicentre trial. The lancet
oncology , 11 (6), 543-552.
- Burnett, A. K., Russell, N. H., Hills, R. K., Hunter, A. E., Kjeldsen,
L., Yin, J., … & Milligan, D. (2013). Optimization of chemotherapy
for younger patients with acute myeloid leukemia: results of the
medical research council AML15 trial. Journal of clinical
oncology , 31 (27), 3360-3368.